U.S. Opioid Use Disorder (OUD) Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, and Online Pharmacies), and Country Forecast, 2023-2030
Report Id | License Type | Price |
---|---|---|
FBI108778 | $ 2850 | |
Total | $ 2850 |